Bullbearadvisor 
Bristol Myers Squibb Co. (BMY) is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. The company offers a diverse portfolio, including small molecules, biologics, and chimeric antigen receptor (CAR-T) cell therapies. Bristol Myers Squibb focuses on therapeutic areas such as oncology, immunology, cardiovascular, and fibrosis. Headquartered in Princeton, New Jersey, the company has a rich history of strategic acquisitions to bolster its research and development capabilities. MarketWatch+1MarketWatch+1Barron's
Over the past 52 weeks, Bristol Myers Squibb's stock has ranged between a low of $39.35 and a high of $63.33. MarketWatch+3Forbes+3MarketWatch+3
Analyst recommendations for Bristol Myers Squibb are as follows:MarketWatch
- Buy: 14 analysts (23.33%)AnaChart
- Hold: 37 analysts (61.67%)AnaChart
- Sell: 9 analysts (15%)AnaChart
This distribution suggests a consensus leaning towards a "Hold" rating for the stock.
Subscribe to our API. See Strong Buy and Sell Signals the Day after They Occur!
